Genekam to attend BIO CEO & Investor Conference
February 26-27, 2024 | New York
Genekam registered with EUDAMED - A step towards meeting the latest IVDR requirements!
Genekam is developing ultrasensitive magnetic beads ELISA, which can be used as point of care. Moreover it will finish within 40 minutes and 10000 times sensitive than conventional ELISA, which need almost a day to be completed and has less sensitive as magnetic beads provide 3D structure for antigen and antibody interaction, hence the results are far better and the results can be see through the naked eyes and read with ELISA reader, if user needs to record the values of absorbance. The test is ready to use and it can be done through any technical person in laboratory and clinics.